These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 16427098

  • 1. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
    Pisanu A, Acquas E, Fenu S, Di Chiara G.
    Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
    [Abstract] [Full Text] [Related]

  • 2. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 May; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 3. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.
    Laplante F, Stevenson CW, Gratton A, Srivastava LK, Quirion R.
    J Neurochem; 2004 Dec; 91(6):1473-82. PubMed ID: 15584923
    [Abstract] [Full Text] [Related]

  • 4. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions.
    Laplante F, Srivastava LK, Quirion R.
    J Neurochem; 2004 Apr; 89(2):314-23. PubMed ID: 15056275
    [Abstract] [Full Text] [Related]

  • 5. Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats.
    Khaimova E, Kandov Y, Israel Y, Cataldo G, Hadjimarkou MM, Bodnar RJ.
    Brain Res; 2004 Nov 12; 1026(2):284-94. PubMed ID: 15488491
    [Abstract] [Full Text] [Related]

  • 6. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K, Takahashi I, Watanabe S, Aono Y, Ikeda H, Saigusa T, Nagase H, Suzuki T, Koshikawa N, Cools AR.
    Neuroscience; 2005 Nov 12; 130(3):745-55. PubMed ID: 15590157
    [Abstract] [Full Text] [Related]

  • 7. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
    Cadoni C, Valentini V, Di Chiara G.
    J Neurochem; 2008 Aug 12; 106(4):1586-93. PubMed ID: 18513369
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- and μ-opioid receptors in mouse medial prefrontal cortex.
    Olianas MC, Dedoni S, Onali P.
    Neurochem Int; 2012 Dec 12; 61(8):1404-16. PubMed ID: 23073238
    [Abstract] [Full Text] [Related]

  • 9. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens.
    MacDonald AF, Billington CJ, Levine AS.
    Brain Res; 2004 Aug 20; 1018(1):78-85. PubMed ID: 15262208
    [Abstract] [Full Text] [Related]

  • 10. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
    Nair SG, Gudelsky GA.
    Synapse; 2005 Dec 15; 58(4):229-35. PubMed ID: 16206181
    [Abstract] [Full Text] [Related]

  • 11. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.
    Solinas M, Zangen A, Thiriet N, Goldberg SR.
    Eur J Neurosci; 2004 Jun 15; 19(12):3183-92. PubMed ID: 15217374
    [Abstract] [Full Text] [Related]

  • 12. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat.
    Nair SG, Gudelsky GA.
    Synapse; 2004 Sep 15; 53(4):202-7. PubMed ID: 15266551
    [Abstract] [Full Text] [Related]

  • 13. NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release.
    Zmarowski A, Sarter M, Bruno JP.
    Eur J Neurosci; 2005 Oct 15; 22(7):1731-40. PubMed ID: 16197513
    [Abstract] [Full Text] [Related]

  • 14. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
    Acquas E, Wilson C, Fibiger HC.
    J Pharmacol Exp Ther; 1997 Apr 15; 281(1):360-8. PubMed ID: 9103518
    [Abstract] [Full Text] [Related]

  • 15. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M, Wang JY, Jia H, Tang JS.
    Brain Res; 2006 Mar 03; 1076(1):68-77. PubMed ID: 16476416
    [Abstract] [Full Text] [Related]

  • 16. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
    Narita M, Matsushima Y, Niikura K, Narita M, Takagi S, Nakahara K, Kurahashi K, Abe M, Saeki M, Asato M, Imai S, Ikeda K, Kuzumaki N, Suzuki T.
    Addict Biol; 2010 Oct 03; 15(4):434-47. PubMed ID: 20731628
    [Abstract] [Full Text] [Related]

  • 17. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN, De Vries TJ, Hogenboom F, Mulder AH.
    J Pharmacol Exp Ther; 1993 Oct 03; 267(1):205-10. PubMed ID: 8229747
    [Abstract] [Full Text] [Related]

  • 18. Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.
    Latagliata EC, Valzania A, Pascucci T, Campus P, Cabib S, Puglisi-Allegra S.
    Psychopharmacology (Berl); 2014 Oct 03; 231(21):4099-108. PubMed ID: 24958228
    [Abstract] [Full Text] [Related]

  • 19. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
    Prus AJ, Huang M, Li Z, Dai J, Meltzer HY.
    Brain Res; 2007 Dec 12; 1184():354-64. PubMed ID: 17988654
    [Abstract] [Full Text] [Related]

  • 20. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
    Shippenberg TS, Bals-Kubik R, Herz A.
    J Pharmacol Exp Ther; 1993 Apr 12; 265(1):53-9. PubMed ID: 8386244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.